Publication|Articles|September 19, 2025
- Pharmaceutical Executive: September 2025
- Volume 45
- Issue 7
Pharmaceutical Executive: September 2025 Interactive Digital Edition
View the Pharmaceutical Executive September 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
4 months ago
Can AI Point the Way?4 months ago
Turning AI Pilots into Enterprise Value4 months ago
Paul Hudson: A Mindset for Miracles4 months ago
How AI is Shaping KOL and DOL Identification4 months ago
Measuring the ROI of SPP Adherence ProgramsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences
2
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
3
GSK Enters Multi-Year Collaboration with Helix to Develop Precision Medications
4
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
5
